Cypress Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
GI
MAA
CGH
CNB
Cypress Capital's MDT Position: Q2 2026 in Review
Cypress Capital reduced its Medtronic (MDT) stake by 2.3% in Q2 2026, selling an estimated $54.8K and leaving 29,337 shares worth $2.3M. The position accounts for 0.62% of the portfolio, ranked #38.
Cypress Capital first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.91M in Q4 2025. 425 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Cypress Capital held 29,337 shares of Medtronic worth $2.3M as of Q2 2026.
- Cypress Capital sold 679 Medtronic shares in Q2 2026, an estimated $54.8K.
- Medtronic made up 0.62% of Cypress Capital's portfolio in Q2 2026, its #38 holding.
- Cypress Capital first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
- Cypress Capital's Medtronic position peaked at $2.91M in Q4 2025.
- 425 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.